cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

  • Mikufan@ani.social
    link
    fedilink
    English
    arrow-up
    1
    arrow-down
    1
    ·
    3 months ago

    All would come with the problem that the companys stop investing into research. This would be compensatable by government funded research, but it would be a very large restructuring.

    I think its ok for them to hold patents for some medicine, as long as they sell it for a reasonable price. Those patents however should expire after like 5 years.